Dr. Joseph Ndika of Valo Therapeutics will host a GEN webinar discussing their workflow which uses Valo’s PeptiCHIPTM platform and Bruker’s timsTOF Ultra to identify tumor-specific antigens from a small quantity of cells. This new method revolutionizes cancer immunotherapies by targeting individual patient’s tumour-specific genomic vulnerabilities. The webinar will cover practices in miniaturized enrichment, performance of HLA class I immunopeptidomics, and the value of prioritizing tumor antigens.
Granular Policy Enforcement for Hybrid Classical-Quantum AI Workflows
Master granular policy enforcement for hybrid classical-quantum AI workflows. Secure your MCP servers with post-quantum encryption and advanced threat detection. The post Granular Policy Enforcement
